Jia Zhong

Quantification and Dynamic Monitoring of EGFR T790M in Plasma Cell-Free DNA by Digital PCR for Prognosis of EGFR-TKI Treatment in Advanced NSCLC

Zhijie Wang, Rui Chen, Shuhang Wang et al. · PLoS ONE · 2014 · 130 citations · Full text

Medicine, Molecular Medicine, Oncology +17

The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma

Minglei Zhuo, Yanfang Guan, Xue Yang et al. · Clinical Cancer Research · 2019 · 96 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Potential Resistance Mechanisms Revealed by Targeted Sequencing from Lung Adenocarcinoma Patients with Primary Resistance to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs)

Jia Zhong, Lei Li, Zhijie Wang et al. · Journal of Thoracic Oncology · 2017 · 59 citations · Full text

Medicine, Oncology, Pharmacology +17

The potential predictive value of circulating immune cell ratio and tumor marker in atezolizumab treated advanced non-small cell lung cancer patients

Minglei Zhuo, Hanxiao Chen, Tianzhuo Zhang et al. · Cancer Biomarkers · 2018 · 52 citations · Full text

Medicine, Immunology, Oncology +17

A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database

Bo Jia, Qiwen Zheng, Jingjing Wang et al. · BMC Cancer · 2020 · 52 citations · Full text

Medicine, Oncology, Surgery +17